Waiting Page 12, Paragraph 3
"The Company generates revenue through three verticals: toll processing, private label production, and licensing its intellectual property. With its current Health Canada licences, Nextleaf Labs can complete sales of cannabis oil and cannabis derived products to other companies that hold the appropriate processing licence. In order to complete any sales of cannabis oil to directly to provincial distributors the Company must be granted an oil sales amendment to its Standard Processing Licence. A distribution authorization will permit the Company to complete sales to other Cannabis Act licensed producers. The distribution authorization is contingent upon “practice lot” production, an evidence package submission and an additional inspection."
https://webfiles.thecse.com/Nextleaf_-_2020-01-28_CSE_Form_2A_-_Updated_Listing_Statement_final_w_FS_and_MDA.pdf?q7iEqzWZdergnt66Nq1TaN3I2KnP2QgA=